RBC Cuts Price Target on Kayne Anderson to $16 From $17, Keeps Outperform Rating

RBC Capital Sticks to Its Buy Rating for Kayne Anderson BDC, Inc. (KBDC)

Kayne Anderson BDC Is Maintained at Outperform by Keefe, Bruyette & Woods

Kayne Anderson BDC, Inc. (KBDC) Receives a Buy from KBW

U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare

Kayne Anderson BDC Inc : Kbw Cuts Target Price to $16 From $16.5

Kayne Anderson BDC’s Resilient Earnings Call Analysis

Kayne Anderson BDC Inc. Files Initial Beneficial Ownership Statement for Senior Vice President Andrew Franklyn Wedderburn-Maxwell

Kayne Anderson BDC reports Q3 EPS 43c, consensus 40c

Kayne Anderson BDC Names Frank Karl President and Andy Wedderburn-Maxwell Senior Vice President

Kayne Anderson BDC, Inc. Appoints Frank Karl as President & Andy Wedderburn-Maxwell as Senior Vice President

Kayne Anderson BDC Q3 EPS $0.43 Beats $0.40 Estimate, Sales $61.373M Beat $59.018M Estimate

Kayne Anderson BDC - Net Investment Income of $30.0 Mln, or $0.43 per Share for Quarter Ended Sept 30, 2025

Press Release: Kayne Anderson BDC, Inc. Announces September 30, 2025 Financial Results and Declares Fourth Quarter 2025 Dividend of $0.40 Per Share

Kayne Anderson BDC Is Maintained at Neutral by UBS

Kayne Anderson BDC Inc to release third quarter 2025 financial results

Kayne Anderson BDC Shares Rise After Upgrade From Keefe Bruyette & Woods

Keefe Bruyette & Woods Upgrades Kayne Anderson BDC to Outperform From Market Perform, Price Target is $16.50

Kayne Anderson BDC upgraded to Outperform from Market Perform at Keefe Bruyette

U.S. RESEARCH ROUNDUP-Berkshire Hathaway, Ford, GM